乳腺癌：按年龄、性别、种族/族裔、分期、分级、病程、选定的 ICD-O-3 肿瘤分型和队列进入时间段进行的 20 年死亡率和生存率比较分析。

Q3 Medicine

Journal of insurance medicine (New York, N.Y.) Pub Date : 2023-07-01 DOI:10.17849/insm-50-2-80-122.1

Anthony F Milano

{"title":"乳腺癌：按年龄、性别、种族/族裔、分期、分级、病程、选定的 ICD-O-3 肿瘤分型和队列进入时间段进行的 20 年死亡率和生存率比较分析。","authors":"Anthony F Milano","doi":"10.17849/insm-50-2-80-122.1","DOIUrl":null,"url":null,"abstract":"Breast cancer remains the most common non-cutaneous malignancy in women in both Europe and the United States and the second leading cause of cancer-related deaths. In this breast cancer mortality and survival study, a US retrospective population-based analysis of 656,501 microscopically confirmed breast cancer cases, 1975-2019, data is derived from the NCI Surveillance Epidemiology & End Results Program, SEER*Stat 8.4.0.1.","PeriodicalId":39345,"journal":{"name":"Journal of insurance medicine (New York, N.Y.)","volume":"50 2","pages":"80-122"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Breast Cancer: 20-Year Comparative Mortality and Survival Analysis by Age, Sex, Race/Ethnicity, Stage, Grade, Disease Duration, Selected ICD-O-3 Oncophenotypes, and Cohort Entry Time-Period.\",\"authors\":\"Anthony F Milano\",\"doi\":\"10.17849/insm-50-2-80-122.1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Breast cancer remains the most common non-cutaneous malignancy in women in both Europe and the United States and the second leading cause of cancer-related deaths. In this breast cancer mortality and survival study, a US retrospective population-based analysis of 656,501 microscopically confirmed breast cancer cases, 1975-2019, data is derived from the NCI Surveillance Epidemiology & End Results Program, SEER*Stat 8.4.0.1.\",\"PeriodicalId\":39345,\"journal\":{\"name\":\"Journal of insurance medicine (New York, N.Y.)\",\"volume\":\"50 2\",\"pages\":\"80-122\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of insurance medicine (New York, N.Y.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17849/insm-50-2-80-122.1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of insurance medicine (New York, N.Y.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17849/insm-50-2-80-122.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

在欧洲和美国，乳腺癌仍然是女性最常见的非皮肤恶性肿瘤，也是癌症相关死亡的第二大原因。在这项乳腺癌死亡率和存活率研究中，对 1975-2019 年间 656,501 例经显微镜确诊的乳腺癌病例进行了基于美国人口的回顾性分析，数据来自 NCI 监测、流行病学和最终结果计划 SEER*Stat 8.4.0.1。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Breast Cancer: 20-Year Comparative Mortality and Survival Analysis by Age, Sex, Race/Ethnicity, Stage, Grade, Disease Duration, Selected ICD-O-3 Oncophenotypes, and Cohort Entry Time-Period.

Breast cancer remains the most common non-cutaneous malignancy in women in both Europe and the United States and the second leading cause of cancer-related deaths. In this breast cancer mortality and survival study, a US retrospective population-based analysis of 656,501 microscopically confirmed breast cancer cases, 1975-2019, data is derived from the NCI Surveillance Epidemiology & End Results Program, SEER*Stat 8.4.0.1.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of insurance medicine (New York, N.Y.) Medicine-Medicine (all)

CiteScore

0.50

自引率

0.00%

发文量

期刊介绍： The Journal of Insurance Medicine is a peer reviewed scientific journal sponsored by the American Academy of Insurance Medicine, and is published quarterly. Subscriptions to the Journal of Insurance Medicine are included in your AAIM membership.